Literature DB >> 19235186

Using genome-wide pathway analysis to unravel the etiology of complex diseases.

Clara C Elbers1, Kristel R van Eijk, Lude Franke, Flip Mulder, Yvonne T van der Schouw, Cisca Wijmenga, N Charlotte Onland-Moret.   

Abstract

Several genome-wide association studies (GWAS) have been published on various complex diseases. Although, new loci are found to be associated with these diseases, still only very little of the genetic risk for these diseases can be explained. As GWAS are still underpowered to find small main effects, and gene-gene interactions are likely to play a role, the data might currently not be analyzed to its full potential. In this study, we evaluated alternative methods to study GWAS data. Instead of focusing on the single nucleotide polymorphisms (SNPs) with the highest statistical significance, we took advantage of prior biological information and tried to detect overrepresented pathways in the GWAS data. We evaluated whether pathway classification analysis can help prioritize the biological pathways most likely to be involved in the disease etiology. In this study, we present the various benefits and limitations of pathway-classification tools in analyzing GWAS data. We show multiple differences in outcome between pathway tools analyzing the same dataset. Furthermore, analyzing randomly selected SNPs always results in significantly overrepresented pathways, large pathways have a higher chance of becoming statistically significant and the bioinformatics tools used in this study are biased toward detecting well-defined pathways. As an example, we analyzed data from two GWAS on type 2 diabetes (T2D): the Diabetes Genetics Initiative (DGI) and the Wellcome Trust Case Control Consortium (WTCCC). Occasionally the results from the DGI and the WTCCC GWAS showed concordance in overrepresented pathways, but discordance in the corresponding genes. Thus, incorporating gene networks and pathway classification tools into the analysis can point toward significantly overrepresented molecular pathways, which cannot be picked up using traditional single-locus analyses. However, the limitations discussed in this study, need to be addressed before these methods can be widely used. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19235186     DOI: 10.1002/gepi.20395

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  94 in total

1.  Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.

Authors:  Daniel J Schaid; Jason P Sinnwell; Gregory D Jenkins; Shannon K McDonnell; James N Ingle; Michiaki Kubo; Paul E Goss; Joseph P Costantino; D Lawrence Wickerham; Richard M Weinshilboum
Journal:  Genet Epidemiol       Date:  2011-12-07       Impact factor: 2.135

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

3.  Pathway analysis of genome-wide association study for bone mineral density.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-04-25       Impact factor: 2.316

Review 4.  Assessing gene-gene interactions in pharmacogenomics.

Authors:  Hsien-Yuan Lane; Guochuan E Tsai; Eugene Lin
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

5.  Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.

Authors:  Yong-Jun Liu; Yan-Fang Guo; Li-Shu Zhang; Yu-Fang Pei; Na Yu; Ping Yu; Christopher J Papasian; Hong-Wen Deng
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

6.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies.

Authors:  Hua Zhong; Xia Yang; Lee M Kaplan; Cliona Molony; Eric E Schadt
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

7.  A versatile gene-based test for genome-wide association studies.

Authors:  Jimmy Z Liu; Allan F McRae; Dale R Nyholt; Sarah E Medland; Naomi R Wray; Kevin M Brown; Nicholas K Hayward; Grant W Montgomery; Peter M Visscher; Nicholas G Martin; Stuart Macgregor
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

Review 8.  Analysing biological pathways in genome-wide association studies.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nat Rev Genet       Date:  2010-12       Impact factor: 53.242

9.  Integrative pathway analysis of a genome-wide association study of (V)O(2max) response to exercise training.

Authors:  Sujoy Ghosh; Juan C Vivar; Mark A Sarzynski; Yun Ju Sung; James A Timmons; Claude Bouchard; Tuomo Rankinen
Journal:  J Appl Physiol (1985)       Date:  2013-08-29

10.  Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma.

Authors:  Mingfeng Zhang; Liming Liang; Nilesh Morar; Anna L Dixon; G Mark Lathrop; Jun Ding; Miriam F Moffatt; William O C Cookson; Peter Kraft; Abrar A Qureshi; Jiali Han
Journal:  Hum Genet       Date:  2011-10-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.